MedTrace Logo

A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing

NCT06392269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 443

Last updated 2026-03-20

No results posted yet for this study

Summary

This is a prospective, multi-center study within the U.S. Study participants will take part in two study visits a minimum of 14 days apart. During each visit, participants will self-collect capillary blood samples. Additionally, a healthcare provide will obtain capillary and venous serum samples. All capillary samples will be collected from the upper arm using the Tasso+ device paired with a commercially-available serum separator gel microtainer. The samples will be shipped to a clinical laboratory and tested for various analytes. Expected analyte values for each participant will be based on their venous sample results which will be compared to Tasso sample results

Conditions

  • Serum Analytes

Interventions

DIAGNOSTIC_TEST

Tasso+SST

Clinical evaluation of capillary blood samples collected using the Tasso+SST device for downstream analyte testing.

Sponsors & Collaborators

  • Tasso Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-18
Primary Completion
2025-04-15
Completion
2025-04-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392269 on ClinicalTrials.gov